OVERVIEW
The market for hemostasis / coagulation analyzers is expected to hit USD 6.44 billion by 2025, increasing from 2020 to 2025 at a CAGR of 9.11%. The high prevalence and high economic burden of blood-related diseases and CVDs, rising healthcare spending has resulted in the use of consumer devices for coagulation analysers.
TABLE OF CONTENT
1 Global Hemostasis/Coagulation Analyzer Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Hemostasis/Coagulation Analyzer Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Hemostasis/Coagulation Analyzer Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Hemostasis/Coagulation Analyzer Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Hemostasis/Coagulation Analyzer Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Hemostasis/Coagulation Analyzer Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Hemostasis/Coagulation Analyzer Market – By Product (Market Size – &
million/billion)
8.1 Clinical Laboratory Analyzers
8.2 Analyzers for Point-of-Care Testing
9 Global Hemostasis/Coagulation Analyzer Market – By Test
9.1 Prothrombin Time
9.2 Activated Clotting Time
9.3 Fibrinogen
9.4 Activated Partial Thromboplastin Time
9.5 Platelet Function
9.6 Heparin & Protamine Dose Response Test for ACT
9.7 Other
10 Global Hemostasis/Coagulation Analyzer Market – By Technology
10.1 Mechanical
10.2 Optical
10.3 Electrochemical
10.4 Other
11 Global Hemostasis/Coagulation Analyzer Market – By End Users
11.1 Clinical Laboratories
11.2 POC
11.3 Others
12 Global Hemostasis/Coagulation Analyzer Market – By Geography (Market Size – &
million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Hemostasis/Coagulation Analyzer Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Hemostasis/Coagulation Analyzer Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Alere Inc.
14.3 Nihon Kohden Corporation
14.4 Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
14.5 Helena Laboratories
14.6 Sysmex Corporation
14.7 Thermo Fisher Scientific Inc.
14.8 Instrumentation Laboratory (A Division of the Werfen Group)
14.9 International Technidyne Corporation (ITC)
14.10 Siemens Healthcare (A Division of Siemens AG)
14.11 Diagnostica Stago Sas
14.12 Company 11 & more
15 Global Hemostasis/Coagulation Analyzer Market – Appendix
15.1 Sources
15.2 Abbreviations